2011
|
Invention
|
Oxazolidinone derivative having inhibitory activity on 11beta-hydroxysteroid dehydrogenase type 1... |
|
Invention
|
Method of generating molecule-function network.
A method of generating a molecule-function netwo... |
2010
|
Invention
|
Inflammatory cytokine release inhibitor. A medicament having inhibitory activity against NF-κB ac... |
2009
|
Invention
|
O-substituted hydroxyaryl derivatives.
A medicament having inhibitory activity against NF-κB act... |
|
Invention
|
Pai-1 inhibitor. Provided is a compound represented by formula (I) having a PAI-1 inhibiting acti... |
|
Invention
|
Pai-1 inhibitor. The compound represented by the following formula (I) and the like have PAI-1 in... |
2008
|
Invention
|
Inhibitor of pai-1 production. The compound represented by the following general formula (I) has ... |
|
Invention
|
Pai-1 production inhibitor. Disclosed is a compound represented by the general formula (I) below,... |
|
Invention
|
Heterocyclic derivative having inhibitory activity on type-i 11 data-hydroxysteroid dehydrogenase... |
|
Invention
|
Heterocyclic derivative having inhibitory activity on type-i 11-hydroxysteroid dehydrogenase. Di... |
|
Invention
|
Medicament for treatment of neurodegenerative diseases.
A medicament for preventive and/or thera... |
|
Invention
|
Inhibitors against activation of nf-kappab.
A method of inhibiting NF-κB activation in a mammal ... |
|
Invention
|
Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1. D... |
|
Invention
|
Oxazolidinone derivative having inhibitory activity on 11-hydroxysteroid dehydrogenase type i. D... |
2007
|
Invention
|
Antiallergic agents.
A medicament for the preventive and/or therapeutic treatment of allergic d... |
|
Invention
|
Describing and storing method of alignment information.
A description and storing method of an a... |
|
Invention
|
N-phenyloxamide derivatives. A compound represented by the following general formula (I) or a sal... |
|
Invention
|
Carboxilic acid derivatives. A compound represented by the following general formula (I) or a sal... |
|
Invention
|
N-phenyloxamidic acid derivative. Disclosed is a compound represented by the general formula (I) ... |
|
Invention
|
Carboxylic acid derivative. Disclosed is a compound represented by the general formula (I), a sal... |
|
Invention
|
Inflammatory cytokine release inhibitor.
A medicament having inhibitory activity against NF-κB ... |
|
Invention
|
Inflammatory cytokine release inhibitor.
A medicament having inhibitory activity against NF-κB a... |
|
Invention
|
N-(3,4-disubstituted phenyl)salicylamide derivative. A compound represented by the formula (I) or... |
|
Invention
|
N-(3,4-disubstituted phenyl) salicylamide derivatives. A compound represented by the following fo... |
|
Invention
|
Antiallergic agents. A medicament for the preventive and/or therapeutic treatment of allergic dis... |
2006
|
Invention
|
Derivative having ppar agonistic activity. A compound of the formula (I):
or a pharmaceutically... |
|
Invention
|
Derivative having ppar agonistic activity. A compound represented by the formula (I), a pharmaceu... |
|
Invention
|
Id symbol unique to structural formula of compound.
A method for generating a character string o... |
|
Invention
|
Inhibitor of plasminogen activator inhibitor-1. A pharmaceutical agent comprising a compound repr... |
2005
|
Invention
|
Method of displaying molecule function network.
A graphical user interface that generates a mole... |
|
Invention
|
Method of displaying molecule function network. A graphical user interface that generates a molec... |
|
Invention
|
Drugs having cyclooxygenase inhibiting activity. Drugs having cyclooxygenase inhibiting activity,... |
|
Invention
|
Method for manufacturing fullerene derivatives. Provided is a method for manufacturing fullerene ... |
2004
|
Invention
|
Medicament for therapeutic and/or preventive treatment of restenosis or reocclusion after vascula... |
|
Invention
|
Plasminogen activator inhibitor-1 inhibitor.
A medicament having inhibitory activity against pl... |
|
Invention
|
Medicament for treatment of dermal pigmentation.
A medicament for preventive and/or therapeutic... |
|
Invention
|
Molecular function network display method.
A graphical user interface that generates a molecule ... |
2003
|
Invention
|
Quinazolin-4-one derivatives.
A medicament having an inhibitory activity against hematopoietic ... |
|
Invention
|
Antiallergic.
A medicament for the preventive and/or therapeutic treatment of allergic diseases... |
|
Invention
|
Medicament for treatment of diabetes.
A medicament for preventive and/or therapeutic treatment ... |
|
Invention
|
Inhibitors against the activation of ap-1 and nfat.
A medicament inhibiting the activation of A... |
|
Invention
|
O-substituted hydroxyaryl derivatives. A medicament having inhibitory activity against NF-κB acti... |
|
Invention
|
Nf-kb activation inhibitors.
A medicament having inhibitory activity against NF-κB activation w... |
|
Invention
|
Remedies for neurodegenerative diseases.
A medicament for preventive and/or therapeutic treatme... |
2002
|
Invention
|
Specific identifiers of amino-acid base sequences. In order to assign specific identifiers to ami... |
2000
|
Invention
|
Method of inferring three-dimensional structure of protein. A method of predicting a scaffold of ... |